Literature DB >> 7926498

The epidemiology of low serum pepsinogen A levels and an international association with gastric cancer rates. EUROGAST Study Group.

P M Webb, K J Hengels, H Møller, D G Newell, D Palli, J B Elder, M P Coleman, G De Backer, D Forman.   

Abstract

BACKGROUND/AIMS: Low serum levels of pepsinogen A are indicative of chronic atrophy, a risk factor for gastric cancer. This study investigated the relationships between low pepsinogen A levels, Helicobacter pylori seropositivity, and gastric cancer rates in 17 populations worldwide.
METHODS: In each center, about 200 randomly selected subjects (50 male and 50 female, aged 25-34 and 55-64 years) provided serum samples for pepsinogen analysis and H. pylori serology.
RESULTS: Cumulative gastric cancer rates were associated with the prevalence of low pepsinogen A levels in men (coefficient, 0.15 [P = 0.06] for mortality; coefficient, 0.36 [P = 0.01] for incidence) but not women. The prevalence of low pepsinogen A levels was also correlated with H. pylori seropositivity in the older age group (r = 0.55; P = 0.02). Low pepsinogen A levels were significantly more common in the older group (7.5% vs. 2.1% in the younger group; P < 0.001), among women (5.5% vs. 4.1% in men; P = 0.04), and among nonsmokers (5.8% vs. 2.9% in current smokers; P = 0.001).
CONCLUSIONS: Low pepsinogen A levels are more common in areas with a high seroprevalence of H. pylori and in men in areas with high rates of gastric cancer. The prevalence of low pepsinogen A levels increases with age, but the excess in women and nonsmokers could reflect factors other than gastric pathology.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7926498     DOI: 10.1016/0016-5085(94)90535-5

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  12 in total

1.  Accuracy of screening for gastric cancer using serum pepsinogen concentrations.

Authors:  F Kitahara; K Kobayashi; T Sato; Y Kojima; T Araki; M A Fujino
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

2.  Gastric cancer screening using the serum pepsinogen test method.

Authors:  Kazumasa Miki
Journal:  Gastric Cancer       Date:  2006-11-24       Impact factor: 7.370

3.  The role of serum pepsinogen in the detection of gastric cancer.

Authors:  Nayoung Kim; Hyun Chae Jung
Journal:  Gut Liver       Date:  2010-09-24       Impact factor: 4.519

4.  Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects.

Authors:  Y Yamaji; T Mitsushima; H Ikuma; M Okamoto; H Yoshida; T Kawabe; Y Shiratori; K Saito; K Yokouchi; M Omata
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

5.  British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma.

Authors:  Matthew Banks; David Graham; Marnix Jansen; Takuji Gotoda; Sergio Coda; Massimiliano di Pietro; Noriya Uedo; Pradeep Bhandari; D Mark Pritchard; Ernst J Kuipers; Manuel Rodriguez-Justo; Marco R Novelli; Krish Ragunath; Neil Shepherd; Mario Dinis-Ribeiro
Journal:  Gut       Date:  2019-07-05       Impact factor: 23.059

6.  Serum pepsinogen concentrations as a measure of gastric acid secretion in Helicobacter pylori-negative and -positive Japanese subjects.

Authors:  Katsunori Iijima; Hitoshi Sekine; Tomoyuki Koike; Akira Imatani; Shuichi Ohara; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2005-10       Impact factor: 7.527

7.  Serum pepsinogen and Helicobacter pylori infection--a Japanese population study.

Authors:  K Toyoda; N Furusyo; T Ihara; H Ikezaki; Y Urita; J Hayashi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-02-22       Impact factor: 3.267

8.  Atrophic gastritis, but not antibody to Helicobacter pylori, is associated with body mass index in a Japanese population.

Authors:  Takehiro Torisu; Takayuki Matsumoto; Yutaka Takata; Toshihiro Ansai; Inho Soh; Shuji Awano; Ikuo Nakamichi; Shuntaro Kagiyama; Kazuo Sonoki; Akihiro Yoshida; Tomoko Hamasaki; Mitsuo Iida; Tadamichi Takehara
Journal:  J Gastroenterol       Date:  2008-10-29       Impact factor: 7.527

9.  Validity of serum pepsinogen I/II ratio for the diagnosis of gastric epithelial dysplasia and intestinal metaplasia during the follow-up of patients at risk for intestinal-type gastric adenocarcinoma.

Authors:  Mário Dinis-Ribeiro; Altamiro da Costa-Pereira; Carlos Lopes; Joana Barbosa; Mateus Guilherme; Luís Moreira-Dias; Helena Lomba-Viana; Rui Silva; Nuno Abreu; Rafael Lomba-Viana
Journal:  Neoplasia       Date:  2004 Sep-Oct       Impact factor: 5.715

10.  Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics.

Authors:  N Broutet; M Plebani; C Sakarovitch; P Sipponen; F Mégraud
Journal:  Br J Cancer       Date:  2003-04-22       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.